Progress in Neurotherapeutics and Neuropsychopharmacology, 2008:
Published annually, volumes in this series provide readers with updates of recent clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, includ...
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Cambridge
Cambridge University Press
2008
|
| Schlagworte: | |
| Online-Zugang: | BSB01 FHN01 Volltext |
| Zusammenfassung: | Published annually, volumes in this series provide readers with updates of recent clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of recent trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practising neurologists as well as clinical and translational neuroscientists |
| Beschreibung: | Vol. 3, 2008. - Title from publisher's bibliographic system (viewed on 05 Oct 2015) |
| Beschreibung: | 1 online resource (xii, 299 pages) |
| ISBN: | 9780511666971 |
| DOI: | 10.1017/CBO9780511666971 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043945963 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 161206s2008 |||| o||u| ||||||eng d | ||
| 020 | |a 9780511666971 |c Online |9 978-0-511-66697-1 | ||
| 024 | 7 | |a 10.1017/CBO9780511666971 |2 doi | |
| 035 | |a (ZDB-20-CBO)CR9780511666971 | ||
| 035 | |a (OCoLC)967605511 | ||
| 035 | |a (DE-599)BVBBV043945963 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-92 | ||
| 082 | 0 | |a 615.78 |2 22 | |
| 245 | 1 | 0 | |a Progress in Neurotherapeutics and Neuropsychopharmacology, 2008 |c editor-in-chief, Jeffrey L. Cummings |
| 246 | 1 | 3 | |a Progress in Neurotherapeutics & Neuropsychopharmacology |
| 264 | 1 | |a Cambridge |b Cambridge University Press |c 2008 | |
| 300 | |a 1 online resource (xii, 299 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Vol. 3, 2008. - Title from publisher's bibliographic system (viewed on 05 Oct 2015) | ||
| 520 | |a Published annually, volumes in this series provide readers with updates of recent clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of recent trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practising neurologists as well as clinical and translational neuroscientists | ||
| 650 | 4 | |a Neuropsychopharmacology / Periodicals | |
| 650 | 4 | |a Nervous system / Diseases / Periodicals | |
| 700 | 1 | |a Cummings, Jeffrey L. |d 1948- |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druckausgabe |z 978-0-521-11561-2 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druckausgabe |z 978-0-521-86255-4 |
| 856 | 4 | 0 | |u https://doi.org/10.1017/CBO9780511666971 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-20-CBO | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029354934 | ||
| 966 | e | |u https://doi.org/10.1017/CBO9780511666971 |l BSB01 |p ZDB-20-CBO |q BSB_PDA_CBO |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1017/CBO9780511666971 |l FHN01 |p ZDB-20-CBO |q FHN_PDA_CBO |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804176892690956288 |
|---|---|
| any_adam_object | |
| author2 | Cummings, Jeffrey L. 1948- |
| author2_role | edt |
| author2_variant | j l c jl jlc |
| author_facet | Cummings, Jeffrey L. 1948- |
| building | Verbundindex |
| bvnumber | BV043945963 |
| collection | ZDB-20-CBO |
| ctrlnum | (ZDB-20-CBO)CR9780511666971 (OCoLC)967605511 (DE-599)BVBBV043945963 |
| dewey-full | 615.78 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.78 |
| dewey-search | 615.78 |
| dewey-sort | 3615.78 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1017/CBO9780511666971 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02701nmm a2200421zc 4500</leader><controlfield tag="001">BV043945963</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">161206s2008 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780511666971</subfield><subfield code="c">Online</subfield><subfield code="9">978-0-511-66697-1</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1017/CBO9780511666971</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-20-CBO)CR9780511666971</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)967605511</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043945963</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-92</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.78</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Progress in Neurotherapeutics and Neuropsychopharmacology, 2008</subfield><subfield code="c">editor-in-chief, Jeffrey L. Cummings</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Progress in Neurotherapeutics & Neuropsychopharmacology</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge</subfield><subfield code="b">Cambridge University Press</subfield><subfield code="c">2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xii, 299 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Vol. 3, 2008. - Title from publisher's bibliographic system (viewed on 05 Oct 2015)</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Published annually, volumes in this series provide readers with updates of recent clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of recent trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practising neurologists as well as clinical and translational neuroscientists</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neuropsychopharmacology / Periodicals</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nervous system / Diseases / Periodicals</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cummings, Jeffrey L.</subfield><subfield code="d">1948-</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">978-0-521-11561-2</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">978-0-521-86255-4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1017/CBO9780511666971</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-20-CBO</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029354934</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/CBO9780511666971</subfield><subfield code="l">BSB01</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">BSB_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/CBO9780511666971</subfield><subfield code="l">FHN01</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">FHN_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV043945963 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:39:24Z |
| institution | BVB |
| isbn | 9780511666971 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029354934 |
| oclc_num | 967605511 |
| open_access_boolean | |
| owner | DE-12 DE-92 |
| owner_facet | DE-12 DE-92 |
| physical | 1 online resource (xii, 299 pages) |
| psigel | ZDB-20-CBO ZDB-20-CBO BSB_PDA_CBO ZDB-20-CBO FHN_PDA_CBO |
| publishDate | 2008 |
| publishDateSearch | 2008 |
| publishDateSort | 2008 |
| publisher | Cambridge University Press |
| record_format | marc |
| spelling | Progress in Neurotherapeutics and Neuropsychopharmacology, 2008 editor-in-chief, Jeffrey L. Cummings Progress in Neurotherapeutics & Neuropsychopharmacology Cambridge Cambridge University Press 2008 1 online resource (xii, 299 pages) txt rdacontent c rdamedia cr rdacarrier Vol. 3, 2008. - Title from publisher's bibliographic system (viewed on 05 Oct 2015) Published annually, volumes in this series provide readers with updates of recent clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of recent trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practising neurologists as well as clinical and translational neuroscientists Neuropsychopharmacology / Periodicals Nervous system / Diseases / Periodicals Cummings, Jeffrey L. 1948- edt Erscheint auch als Druckausgabe 978-0-521-11561-2 Erscheint auch als Druckausgabe 978-0-521-86255-4 https://doi.org/10.1017/CBO9780511666971 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Progress in Neurotherapeutics and Neuropsychopharmacology, 2008 Neuropsychopharmacology / Periodicals Nervous system / Diseases / Periodicals |
| title | Progress in Neurotherapeutics and Neuropsychopharmacology, 2008 |
| title_alt | Progress in Neurotherapeutics & Neuropsychopharmacology |
| title_auth | Progress in Neurotherapeutics and Neuropsychopharmacology, 2008 |
| title_exact_search | Progress in Neurotherapeutics and Neuropsychopharmacology, 2008 |
| title_full | Progress in Neurotherapeutics and Neuropsychopharmacology, 2008 editor-in-chief, Jeffrey L. Cummings |
| title_fullStr | Progress in Neurotherapeutics and Neuropsychopharmacology, 2008 editor-in-chief, Jeffrey L. Cummings |
| title_full_unstemmed | Progress in Neurotherapeutics and Neuropsychopharmacology, 2008 editor-in-chief, Jeffrey L. Cummings |
| title_short | Progress in Neurotherapeutics and Neuropsychopharmacology, 2008 |
| title_sort | progress in neurotherapeutics and neuropsychopharmacology 2008 |
| topic | Neuropsychopharmacology / Periodicals Nervous system / Diseases / Periodicals |
| topic_facet | Neuropsychopharmacology / Periodicals Nervous system / Diseases / Periodicals |
| url | https://doi.org/10.1017/CBO9780511666971 |
| work_keys_str_mv | AT cummingsjeffreyl progressinneurotherapeuticsandneuropsychopharmacology2008 AT cummingsjeffreyl progressinneurotherapeuticsneuropsychopharmacology |